Hsbc Holdings PLC Homology Medicines, Inc. Transaction History

Hsbc Holdings PLC

  • $145 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.55 - $3.01 $2,645 - $5,138
-1,707 Reduced 9.9%
15,531 $25,000
Q2 2022

Aug 11, 2022
SELL
$1.39 - $3.12 $289 - $648
-208 Reduced 1.19%
17,238 $35,000
Q1 2022

May 16, 2022
BUY
$2.6 - $4.17 $540 - $867
208 Added 1.21%
17,446 $52,000
Q4 2021

Feb 11, 2022
BUY
$3.64 - $7.78 $62,746 - $134,111
17,238 New
17,238 $0

Others Institutions Holding FIXX

# of Institutions
5
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email